Guggenheim maintains Buy on Absci, raises price target to $15

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Guggenheim analyst Vamil Divan maintained a Buy rating on Absci (NASDAQ: ABSI) and raised the price target from $10 to $15.

powered bylight_fuzz_icon
43087031

*this image is generated using AI for illustrative purposes only.

Guggenheim analyst Vamil Divan has maintained a Buy rating on Absci (NASDAQ: ABSI) and raised the price target for the stock. The new price target is set at $15, an increase from the previous target of $10.

Rating and Target Details

The decision to maintain the Buy rating reflects continued confidence in the company's prospects. The revised price target suggests a potential upside based on the firm's valuation methodology.

Metric Value
Rating Buy
Previous Price Target $10
New Price Target $15
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific catalysts or milestones does Guggenheim expect Absci to achieve to justify the increased price target?

How might this rating upgrade influence investor sentiment and trading volume for Absci in the short term?

What are the potential risks or challenges that could prevent Absci from reaching the new $15 price target?

like17
dislike